Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to discover and develop anti-viral drug candidates for COVID-19.
Tags:
Source: Anixa Biosciences
Credit:
